These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34758340)

  • 1. Interaction of Aluminum-adjuvanted Recombinant P[4] Protein Antigen With Preservatives: Storage Stability and Backbone Flexibility Studies.
    Sawant N; Joshi SB; Weis DD; Volkin DB
    J Pharm Sci; 2022 Apr; 111(4):970-981. PubMed ID: 34758340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens.
    Agarwal S; Hickey JM; McAdams D; White JA; Sitrin R; Khandke L; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):476-487. PubMed ID: 31589875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies.
    Sharma N; Jerajani K; Wan Y; Kumru OS; Pullagurla SR; Ogun O; Mapari S; Brendle S; Christensen ND; Batwal S; Mahedvi M; Rao H; Dogar V; Chandrasekharan R; Shaligram U; Volkin DB; Joshi SB
    J Pharm Sci; 2023 Feb; 112(2):458-470. PubMed ID: 36462710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine.
    Kaur K; Xiong J; Sawant N; Agarwal S; Hickey JM; Holland DA; Mukhopadhyay TK; Brady JR; Dalvie NC; Tracey MK; Love KR; Love JC; Weis DD; Joshi SB; Volkin DB
    J Pharm Sci; 2021 Mar; 110(3):1054-1066. PubMed ID: 33278412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens.
    Sawant N; Kaur K; Holland DA; Hickey JM; Agarwal S; Brady JR; Dalvie NC; Tracey MK; Velez-Suberbie ML; Morris SA; Jacob SI; Bracewell DG; Mukhopadhyay TK; Love KR; Love JC; Joshi SB; Volkin DB
    J Pharm Sci; 2021 Mar; 110(3):1042-1053. PubMed ID: 33285182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges.
    Kumar P; Holland DA; Secrist K; Taskar P; Dotson B; Saleh-Birdjandi S; Adewunmi Y; Doering J; Mantis NJ; Volkin DB; Joshi SB
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlating the Effects of Antimicrobial Preservatives on Conformational Stability, Aggregation Propensity, and Backbone Flexibility of an IgG1 mAb.
    Arora J; Joshi SB; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2017 Jun; 106(6):1508-1518. PubMed ID: 28212986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant.
    Caringal RT; Hickey JM; Sharma N; Jerajani K; Bewaji O; Brendle S; Christensen N; Batwal S; Mahedvi M; Rao H; Dogar V; Chandrasekharan R; Shaligram U; Joshi SB; Volkin DB
    Vaccines (Basel); 2024 May; 12(6):. PubMed ID: 38932309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between preservatives and a monoclonal antibody in support of multidose formulation development.
    Karunaratne SP; Jolliffe MC; Trayton I; Shanmugam RK; Darton NJ; Weis DD
    Int J Pharm; 2023 Dec; 648():123600. PubMed ID: 37967687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development.
    Jerajani K; Wan Y; Hickey JM; Kumru OS; Sharma N; Pullagurla SR; Ogun O; Mapari S; Whitaker N; Brendle S; Christensen ND; Batwal S; Mahedvi M; Rao H; Dogar V; Chandrasekharan R; Shaligram U; Joshi SB; Volkin DB
    J Pharm Sci; 2022 Nov; 111(11):2983-2997. PubMed ID: 35914546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques.
    Gupta S; Kaisheva E
    AAPS PharmSci; 2003; 5(2):E8. PubMed ID: 12866935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-biochemical evaluations of phenol and thimerosal as antigen preservatives in Montenegro skin test.
    Mayrink W; Coelho GL; Guimarães TM; de Andrade HM; de Castro Peres E; da Costa CA; de Toledo Vde P
    Acta Trop; 2006 Apr; 98(1):87-93. PubMed ID: 16527224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a capillary electrophoresis method for simultaneous determination of preservatives in pharmaceutical formulations.
    Jaworska M; Szulińska Z; Wilk M
    J Sep Sci; 2005 Feb; 28(2):137-43. PubMed ID: 15754820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant.
    McAdams D; Lakatos K; Estrada M; Chen D; Plikaytis B; Sitrin R; White JA
    J Immunol Methods; 2021 Jul; 494():113056. PubMed ID: 33857473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
    Kumru OS; Sanyal M; Friedland N; Hickey J; Joshi R; Weidenbacher P; Do J; Cheng YC; Kim PS; Joshi SB; Volkin DB
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of paraben sorption to polyethylene terephthalate: a freeze-thaw phenomenon.
    Bergquist PA; Kemp EA; Seburg RA; Zhu LM
    PDA J Pharm Sci Technol; 2006; 60(4):240-7. PubMed ID: 17089692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview.
    Stroppel L; Schultz-Fademrecht T; Cebulla M; Blech M; Marhöfer RJ; Selzer PM; Garidel P
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partitioning of parabens between phases of submicron emulsions stabilized with egg lecithin.
    Watrobska-Swietlikowska D; Sznitowska M
    Int J Pharm; 2006 Apr; 312(1-2):174-8. PubMed ID: 16472951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.
    Wagner L; Verma A; Meade BD; Reiter K; Narum DL; Brady RA; Little SF; Burns DL
    Clin Vaccine Immunol; 2012 Sep; 19(9):1465-73. PubMed ID: 22815152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations.
    Jerajani K; Wan Y; Kumru OS; Pullagurla SR; Kumar P; Sharma N; Ogun O; Mapari S; Brendle S; Christensen ND; Batwal S; Mahedvi M; Rao H; Dogar V; Chandrasekharan R; Shaligram U; Joshi SB; Volkin DB
    J Pharm Sci; 2023 Feb; 112(2):446-457. PubMed ID: 36096284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.